Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Roger B Cohen

Professor of Medicine at the Hospital of the University of Pennsylvania
Associate Director Clinical Research Abramson Cancer Center, Abramson Cancer Center
Chief Clinical Research Officer, Abramson Cancer Center
Department: Medicine

Contact information
Division of Hematology-Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-205
Philadelphia, PA 19104
Office: 215-662-4469
Fax: 215-349-5326
Education:
A.B. (Biochemical Sciences)
Harvard College (magna cum laude), 1976.
M.D. (Medicine)
Harvard Medical School, 1980.
Post-Graduate Training
Intern in Medicine, Mount Sinai Hospital, New York, NY, 1980-1981.
Resident in Medicine, Mount Sinai Hospital, New York, NY, 1981-1982.
Research Fellow, Gene Structure & Expression, Sloan-Kettering Cancer Research Institute, New York, NY, 1982-1985.
Clinical Fellowship in Hematology, Mount Sinai Hospital, New York, NY, 1985-1986.
Fellowship, Laboratory of Molecular Hematology, NHLBI, Bethesda, MD, 1986-1989.
Clinical Fellowship, Medical Oncology, National Cancer Institute, Bethesda, MD, 1991-1993.
Certifications
Internal Medicine, ABIM, 1984.
Hematology, ABIM, 1986.
Medical Oncology, ABIM, 1993.
Medical Oncology, ABIM (re-certified), 2015.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Bauml Joshua, Haas Andrew, Simone Charles B, Li Susan Q, Cohen Roger B, Langer Corey J, Mao Jun J: Acupuncture for Dyspnea in Lung Cancer: Results of a Feasibility Trial. Integrative cancer therapies Apr 2016.

Maquilan Genevieve, Grover Surbhi, Xanthopoulos Eric, Evans Tracey L, Aggarwal Charu, Langer Corey J, Cohen Roger B, Stevenson James P, Simone Charles B, Rengan Ramesh: Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment. American journal of clinical oncology Apr 2016.

Sedrak Mina S, Cohen Roger B, Merchant Raina M, Schapira Marilyn M: Cancer Communication in the Social Media Age. JAMA oncology Mar 2016.

Ahn Peter H, Mitra Nandita, Alonso-Basanta Michelle, Adappa Nithin D, Palmer James N, O'Malley Bert W, Rassekh Christopher H, Chalian Ara, Cohen Roger B, Lin Alexander: Nodal metastasis and elective nodal level treatment in sinonasal small-cell and sinonasal undifferentiated carcinoma: a surveillance, epidemiology and end results analysis. The British journal of radiology 89(1058): 20150488, Feb 2016.

Sarantopoulos John, Shapiro Geoffrey I, Cohen Roger B, Clark Jeffrey W, Kauh John S, Weiss Glen J, Cleary James M, Mahalingam Devalingam, Pickard Michael D, Faessel Hélène M, Berger Allison J, Burke Kristine, Mulligan George, Dezube Bruce J, Harvey R Donald: Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 22(4): 847-57, Feb 2016.

Chiorean EG, Hurwitz HI, Cohen RB, Schwartz JD, Dalal RP, Fox FE, Gao L, Sweeney CJ.: Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumors. Ann Oncol 26(6): 1230-7, March 2015

Rixe Olivier, Puzanov Igor, LoRusso Patricia M, Cohen Roger B, Morris John C, Olowokure Olugbenga O, Yin Jian Y, Doroumian Séverine, Shen Liji, Olszanski Anthony J: Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies. Anti-cancer drugs 26(7): 785-92, Aug 2015.

Grover Surbhi, Swisher-McClure Samuel, Mitra Nandita, Li Jiaqi, Cohen Roger B, Ahn Peter H, Lukens John N, Chalian Ara A, Weinstein Gregory S, O'Malley Bert W, Lin Alexander: Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes. International journal of radiation oncology, biology, physics 92(3): 594-601, Jul 2015.

von Mehren Margaret, Bookman Michael, Meropol Neal J, Weiner Louis M, Sherman Eric, Li Jinhui, Knoblauch Roland, Parekh Trilok, Cohen Roger B: Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies. Cancer chemotherapy and pharmacology 75(5): 1047-55, May 2015.

Chiorean E G, Hurwitz H I, Cohen R B, Schwartz J D, Dalal R P, Fox F E, Gao L, Sweeney C J: Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 26(6): 1230-7, Mar 2015.

back to top
Last updated: 07/14/2016
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration